Page last updated: 2024-11-05

4-chloro-1-naphthol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-chloro-1-naphthol: RN given refers to cpd with specified locants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11787
CHEMBL ID3310663
SCHEMBL ID3935
MeSH IDM0085680

Synonyms (44)

Synonym
einecs 210-068-5
4-chloro-alpha-naphthol
nsc 44345
EN300-20271
4-chloro-.alpha.-naphthol
4-chloro-1-naphthol
1-naphthalenol, 4-chloro-
1-naphthol, 4-chloro-
nsc-44345
nsc44345
1-chloro-4-hydroxynaphthalene
604-44-4
C-5180
4-chloro-1-naphthol, tablet
4-chloro-1-naphthol, crystalline
C2291
4-cn
lvspdzagcbeqav-uhfffaoysa-
inchi=1/c10h7clo/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6,12h
4-chloronaphthalen-1-ol
4-chloronaphthol
AKOS000120385
4-chloranylnaphthalen-1-ol
A832730
4-chloro-1-naphthalenol
4-chloro-naphthalen-1-ol
4-chloro-1-hydroxynaphthalene
FT-0617983
C-5181
1-naphthalenol,4-chloro-
SCHEMBL3935
CHEMBL3310663
DTXSID3060536
mfcd00003974
STR01788
CS-W007967
1-chloro-4-naphthol
4-chloro-1-naphthol, for analytical purposes, >=99.0%
4-chloro-1-naphthol, >=95.0% (hplc), tablet (~32 mg each)
P4NNY2FQ2A
AMY202003300
D70242
SY045975
Z104477546
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1182519Radioprotective activity against gamma-irradiated human MOLT4 cells preincubated for 1 hr at 100 to 400 uM before gamma-irradiation measured after 18 hrs by erythrosine B dye-exclusion test2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (39.39)18.7374
1990's2 (6.06)18.2507
2000's4 (12.12)29.6817
2010's12 (36.36)24.3611
2020's2 (6.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.33 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]